Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q88916151 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000057.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q88916151 | ||
| 024 | ‡a 0000-0003-1103-9608 ‡2 orcid | ||
| 024 | ‡a 8600082600 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q88916151 | ||
| 100 | 0 | ‡a Hanne Andersen ‡c chercheur ‡9 fr | |
| 400 | 0 | ‡a Hanne Andersen ‡c American virologist ‡9 en | |
| 400 | 0 | ‡a Hanne Andersen ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates | ||
| 670 | ‡a Author's A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice | ||
| 670 | ‡a Author's A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | ||
| 670 | ‡a Author's Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters | ||
| 670 | ‡a Author's Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method | ||
| 670 | ‡a Author's Animal models for COVID-19 | ||
| 670 | ‡a Author's Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses | ||
| 670 | ‡a Author's Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret | ||
| 670 | ‡a Author's Correlates of protection against SARS-CoV-2 in rhesus macaques | ||
| 670 | ‡a Author's DNA vaccine protection against SARS-CoV-2 in rhesus macaques | ||
| 670 | ‡a Author's Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus | ||
| 670 | ‡a Author's Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates | ||
| 670 | ‡a Author's Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection | ||
| 670 | ‡a Author's Identification of the ancestral killer immunoglobulin-like receptor gene in primates | ||
| 670 | ‡a Author's Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates | ||
| 670 | ‡a Author's Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration | ||
| 670 | ‡a Author's Induction of broadly neutralizing H1N1 influenza antibodies by vaccination | ||
| 670 | ‡a Author's Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses | ||
| 670 | ‡a Author's mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates | ||
| 670 | ‡a Author's Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. | ||
| 670 | ‡a Author's Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques | ||
| 670 | ‡a Author's Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates | ||
| 670 | ‡a Author's Rapid development of a DNA vaccine for Zika virus | ||
| 670 | ‡a Author's REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters | ||
| 670 | ‡a Author's SARS-CoV-2 infection protects against rechallenge in rhesus macaques | ||
| 670 | ‡a Author's Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques | ||
| 670 | ‡a Author's TCRbeta enhancer activation occurs in some but not all cells with T cell lineage developmental potential | ||
| 670 | ‡a Author's Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination | ||
| 909 | ‡a (orcid) 0000000311039608 ‡9 1 | ||
| 909 | ‡a (scopus) 8600082600 ‡9 1 | ||
| 912 | ‡a evaluationofthemrna1273vaccineagainstsarscov2innonhumanprimates ‡A Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates ‡9 1 | ||
| 919 | ‡a sarscov2infectionprotectsagainstrechallengeinrhesusmacaques ‡A SARS-CoV-2 infection protects against rechallenge in rhesus macaques ‡9 1 | ||
| 919 | ‡a dnavaccineprotectionagainstsarscov2inrhesusmacaques ‡A DNA vaccine protection against SARS-CoV-2 in rhesus macaques ‡9 1 | ||
| 919 | ‡a singleshotad26vaccineprotectsagainstsarscov2inrhesusmacaques ‡A Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques ‡9 1 | ||
| 919 | ‡a tcrbetaenhanceractivationoccursinsomebutnotallcellswithtcelllineagedevelopmentalpotential ‡A TCRbeta enhancer activation occurs in some but not all cells with T cell lineage developmental potential ‡9 1 | ||
| 919 | ‡a rapiddevelopmentofadnavaccineforzikavirus ‡A Rapid development of a DNA vaccine for Zika virus ‡9 1 | ||
| 919 | ‡a protectiveantibodieselicitedbysarscov2spikeproteinvaccinationareboostedinthelungafterchallengeinnonhumanprimates ‡A Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates ‡9 1 | ||
| 919 | ‡a zikavirusprotectionbyasinglelowdosenucleosidemodifiedmrnavaccination ‡A Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination ‡9 1 | ||
| 919 | ‡a priorexposuretozikavirussignificantlyenhancespeakdengue2viremiainrhesusmacaques ‡A Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques ‡9 1 | ||
| 919 | ‡a newcastlediseasevirusvectoredvaccinesexpressingthehemagglutininorneuraminidaseproteinofh5n1highlypathogenicavianinfluenzavirusprotectagainstviruschallengeinmonkeys ‡A Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. ‡9 1 | ||
| 919 | ‡a mrna1273protectsagainstsarscov2betainfectioninnonhumanprimates ‡A mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates ‡9 1 | ||
| 919 | ‡a mosaicnanoparticledisplayofdiverseinfluenzavirushemagglutininselicitsbroadbcellresponses ‡A Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses ‡9 1 | ||
| 919 | ‡a inductionofbroadlyneutralizingh1n1influenzaantibodiesbyvaccination ‡A Induction of broadly neutralizing H1N1 influenza antibodies by vaccination ‡9 1 | ||
| 919 | ‡a immunogenicityofhivviruslikeparticlesinrhesusmacaquesbyintranasaladministration ‡A Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration ‡9 1 | ||
| 919 | ‡a immunecorrelatesofprotectionbymrna1273vaccineagainstsarscov2innonhumanprimates ‡A Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates ‡9 1 | ||
| 919 | ‡a identificationoftheancestralkillerimmunoglobulinlikereceptorgeneinprimates ‡A Identification of the ancestral killer immunoglobulin-like receptor gene in primates ‡9 1 | ||
| 919 | ‡a hemagglutininstemnanoparticlesgenerateheterosubtypicinfluenzaprotection ‡A Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection ‡9 1 | ||
| 919 | ‡a correlatesofprotectionagainstsarscov2inrhesusmacaques ‡A Correlates of protection against SARS-CoV-2 in rhesus macaques ‡9 1 | ||
| 919 | ‡a electroporationofsyntheticdnaantigensoffersprotectioninnonhumanprimateschallengedwithhighlypathogenicavianinfluenzavirus ‡A Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus ‡9 1 | ||
| 919 | ‡a recombinantsubunitbasedzikavirusvaccineisefficaciousinnonhumanprimates ‡A A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates ‡9 1 | ||
| 919 | ‡a singleimmunizationwithnucleosidemodifiedmrnavaccineselicitsstrongcellularandhumoralimmuneresponsesagainstsarscov2inmice ‡A A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice ‡9 1 | ||
| 919 | ‡a viruslikeparticlevaccineforepidemicchikungunyavirusprotectsnonhumanprimatesagainstinfection ‡A A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection ‡9 1 | ||
| 919 | ‡a ad26vaccineprotectsagainstsarscov2severeclinicaldiseaseinhamsters ‡A Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters ‡9 1 | ||
| 919 | ‡a aerosolizedadenovirusvectoredvaccineasanalternativevaccinedeliverymethod ‡A Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method ‡9 1 | ||
| 919 | ‡a animalmodelsforcovid19 ‡A Animal models for COVID-19 ‡9 1 | ||
| 919 | ‡a authorcorrectionmosaicnanoparticledisplayofdiverseinfluenzavirushemagglutininselicitsbroadbcellresponses ‡A Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses ‡9 1 | ||
| 919 | ‡a regncov2antibodiespreventandtreatsarscov2infectioninrhesusmacaquesandhamsters ‡A REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters ‡9 1 | ||
| 919 | ‡a comparativeefficacyofhemagglutininnucleoproteinandmatrix2proteingenebasedvaccinationagainsth5n1influenzainmouseandferret ‡A Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret ‡9 1 | ||
| 996 | ‡2 RERO|A013328185 | ||
| 996 | ‡2 BIBSYS|8081885 | ||
| 996 | ‡2 ISNI|0000000114464488 | ||
| 996 | ‡2 DBC|87097968058767 | ||
| 996 | ‡2 BIBSYS|90849868 | ||
| 996 | ‡2 LC|n 2014046300 | ||
| 996 | ‡2 SELIBR|256853 | ||
| 996 | ‡2 SUDOC|225767015 | ||
| 996 | ‡2 W2Z|11066029 | ||
| 996 | ‡2 SUDOC|254125786 | ||
| 996 | ‡2 DNB|1059754096 | ||
| 996 | ‡2 ISNI|0000000032726747 | ||
| 996 | ‡2 ISNI|0000000364698906 | ||
| 996 | ‡2 BIBSYS|10030546 | ||
| 996 | ‡2 LC|n 96119934 | ||
| 996 | ‡2 NII|DA19875599 | ||
| 996 | ‡2 DBC|87097948306632 | ||
| 996 | ‡2 ARBABN|000068351 | ||
| 996 | ‡2 NKC|xx0112040 | ||
| 996 | ‡2 BIBSYS|90931488 | ||
| 996 | ‡2 DBC|87097968788749 | ||
| 996 | ‡2 NUKAT|n 2010132274 | ||
| 996 | ‡2 LC|n 93026760 | ||
| 996 | ‡2 BIBSYS|4078531 | ||
| 996 | ‡2 DBC|87097969871321 | ||
| 996 | ‡2 NUKAT|n 93080072 | ||
| 996 | ‡2 NSK|000000694 | ||
| 996 | ‡2 BIBSYS|7077418 | ||
| 996 | ‡2 SELIBR|368389 | ||
| 996 | ‡2 NTA|069429774 | ||
| 996 | ‡2 NUKAT|n 2003068292 | ||
| 996 | ‡2 BIBSYS|15045979 | ||
| 996 | ‡2 BIBSYS|90105395 | ||
| 996 | ‡2 BIBSYS|13024250 | ||
| 996 | ‡2 CAOONL|ncf11625539 | ||
| 996 | ‡2 DBC|87097968058740 | ||
| 996 | ‡2 NUKAT|n 2007010307 | ||
| 996 | ‡2 PLWABN|9810549924705606 | ||
| 996 | ‡2 DBC|87097919386597 | ||
| 996 | ‡2 DNB|1055785205 | ||
| 996 | ‡2 LC|no 94022549 | ||
| 996 | ‡2 W2Z|8052964 | ||
| 996 | ‡2 DNB|132199440 | ||
| 996 | ‡2 BIBSYS|1682591864480 | ||
| 996 | ‡2 DBC|87097946365151 | ||
| 996 | ‡2 BIBSYS|5243 | ||
| 996 | ‡2 RERO|A002927873 | ||
| 996 | ‡2 ISNI|0000000121184353 | ||
| 996 | ‡2 LC|n 96000135 | ||
| 996 | ‡2 DBC|87097968955882 | ||
| 996 | ‡2 J9U|987007351626205171 | ||
| 996 | ‡2 DBC|87097968059550 | ||
| 996 | ‡2 DBC|87097968310148 | ||
| 996 | ‡2 BIBSYS|2104183 | ||
| 996 | ‡2 SZ|118502794 | ||
| 996 | ‡2 SIMACOB|273233763 | ||
| 996 | ‡2 LIH|LNB:BR,_q_;=B_m_ | ||
| 996 | ‡2 NTA|241936888 | ||
| 996 | ‡2 DBC|87097968777631 | ||
| 996 | ‡2 DBC|87097969349269 | ||
| 996 | ‡2 BNF|13079177 | ||
| 996 | ‡2 W2Z|12058232 | ||
| 996 | ‡2 DBC|87097968058961 | ||
| 996 | ‡2 BIBSYS|90575110 | ||
| 996 | ‡2 BIBSYS|12058232 | ||
| 996 | ‡2 BIBSYS|8052964 | ||
| 996 | ‡2 BNF|14819245 | ||
| 996 | ‡2 DE633|pe1200 | ||
| 996 | ‡2 DBC|87097990060147 | ||
| 996 | ‡2 DBC|87097968058724 | ||
| 996 | ‡2 BIBSYS|8051936 | ||
| 996 | ‡2 J9U|987007337578705171 | ||
| 996 | ‡2 BIBSYS|5011918 | ||
| 996 | ‡2 ISNI|000000039955403X | ||
| 996 | ‡2 BIBSYS|2136256 | ||
| 996 | ‡2 SUDOC|12821371X | ||
| 996 | ‡2 ISNI|0000000459338081 | ||
| 996 | ‡2 BNF|16610259 | ||
| 996 | ‡2 BIBSYS|13023279 | ||
| 996 | ‡2 BIBSYS|90288070 | ||
| 996 | ‡2 BNC|981060950368206706 | ||
| 996 | ‡2 DBC|87097968058759 | ||
| 996 | ‡2 NTA|243068484 | ||
| 996 | ‡2 ISNI|0000000488816521 | ||
| 996 | ‡2 DBC|870979136213296 | ||
| 996 | ‡2 ISNI|0000000392794508 | ||
| 996 | ‡2 DBC|87097968058732 | ||
| 996 | ‡2 LIH|LNB:C_v_G_n_;=B__ | ||
| 996 | ‡2 DNB|118502794 | ||
| 996 | ‡2 W2Z|1682591864480 | ||
| 996 | ‡2 NII|DA13436676 | ||
| 996 | ‡2 DBC|87097968131758 | ||
| 996 | ‡2 ISNI|0000000050414931 | ||
| 996 | ‡2 DBC|87097990060554 | ||
| 996 | ‡2 LC|n 2020044641 | ||
| 996 | ‡2 NTA|408113227 | ||
| 996 | ‡2 BIBSYS|10069529 | ||
| 996 | ‡2 NTA|303939362 | ||
| 996 | ‡2 DBC|87097919202550 | ||
| 996 | ‡2 LNB|LNC10-000080276 | ||
| 996 | ‡2 LNB|LNC10-000080277 | ||
| 996 | ‡2 CAOONL|ncf12109344 | ||
| 996 | ‡2 DBC|87097919072002 | ||
| 996 | ‡2 SKMASNL|vtls013111298 | ||
| 996 | ‡2 J9U|987007446809305171 | ||
| 996 | ‡2 J9U|987007367057305171 | ||
| 996 | ‡2 BIBSYS|11066029 | ||
| 996 | ‡2 SUDOC|055339581 | ||
| 996 | ‡2 LC|no2001047408 | ||
| 996 | ‡2 DBC|87097968189772 | ||
| 996 | ‡2 NTA|080264875 | ||
| 996 | ‡2 DBC|87097968710820 | ||
| 996 | ‡2 BIBSYS|1059028 | ||
| 996 | ‡2 LIH|LNB:V-82461;=BH | ||
| 996 | ‡2 ISNI|0000000044041585 | ||
| 996 | ‡2 W2Z|13023279 | ||
| 996 | ‡2 DBC|87097968170095 | ||
| 996 | ‡2 RERO|A012878627 | ||
| 996 | ‡2 DNB|1045568155 | ||
| 996 | ‡2 DBC|87097968856302 | ||
| 996 | ‡2 DBC|87097990060139 | ||
| 996 | ‡2 DBC|87097968626382 | ||
| 996 | ‡2 DBC|87097939045109 | ||
| 996 | ‡2 PLWABN|9810613502005606 | ||
| 996 | ‡2 ISNI|0000000439574378 | ||
| 996 | ‡2 VLACC|000002436 | ||
| 996 | ‡2 SIMACOB|6171491 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
